Interleukin-10 expression induced by adeno-associated virus vector suppresses proteinuria in Zucker obese rats

Gene Therapy

Volumn 19, Issue 5, 2012, Pages 476-482

  Ogura, M ^a   Urabe, M ^a   Akimoto, T ^a   Onishi, A ^a   Ito, C ^a   Ito, T ^a   Tsukahara, T ^a   Mizukami, H ^a   Kume, A ^a   Muto, S ^a   Kusano, E ^a   Ozawa, K ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

glomerular epithelial cells; glomerular hyperfiltration; glucose intolerance; nephrin; obesity

Indexed keywords

ADENOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; NEPHRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GENE EXPRESSION; GLOMERULUS BASEMENT MEMBRANE; KIDNEY HYPERTROPHY; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; TREATMENT OUTCOME; VIRAL GENE THERAPY;

ANIMALS; DEPENDOVIRUS; GENETIC VECTORS; INTERLEUKIN-10; KIDNEY; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; OBESITY; PROTEINURIA; RATS; RATS, ZUCKER;

ADENO-ASSOCIATED VIRUS; RATTUS;

EID: 84862154208     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.183     Document Type: Article

References (31)

1. Kambham N, Markowitz GS, Valeri M, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 39: 1498-1509. (Pubitemid 32281241)
2. Ramirez SP, McClellan W, Port FK, Hsu SIH. Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 2002; 1: 1907-1917. (Pubitemid 34700617)
3. Iseki K, Ikemiya K, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876. (Pubitemid 38591038)
4. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis 2006; 47: 396-405. (Pubitemid 43255172)
5. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14: 1480-1486. (Pubitemid 36687049)
6. Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis 2008; 52: 58-65.
7. Kasiske BL, Cleary MP, O'Donnell MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 1985; 106: 598-604.
8. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulinlike growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999; 15: 314-322. (Pubitemid 29535090)
9. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells. potential role in glomerulosclerosis. Kidney Int 1999; 56: 860-872. (Pubitemid 29411714)
10. Keane WF. Lipids and the kidney. Kidney Int 1994; 46: 910-920. (Pubitemid 24272052)
11. Mu W, Ouyang X, Agarwal A, Zhang L, Long DA, Cruz PE et al. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005; 16: 3651-3660. (Pubitemid 46211286)
12. Yoshioka T, Okada T, Maeda Y, Ikeda U, Shimpo M, Nomoto T et al. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice. Gene Therapy 2004; 11: 1772-1779. (Pubitemid 40028538)
13. Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY et al. Interleukin-10 prevents dietinduced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009; 58: 2525-2535.
14. Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003; 88: 1055-1058. (Pubitemid 36337756)
15. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 167-182. (Pubitemid 30227764)
16. Kasiske BL, O'Donnel MP, Cleary MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988; 33: 667-672. (Pubitemid 18083115)
17. Li MC, He SH. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 2004; 10: 620-625.
18. Ito T, Okada T, Miyashita H, Nomoto T, Nonaka-Sarukawa M, Uchibori R et al. Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats. Circ Res 2007; 101: 734-741. (Pubitemid 47494104)
19. Alderson NL, Chachich ME, Youssef NN, Beattie RJ, Nachtigal M, Thorpe SR et al. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. Kidney Int 2003; 63: 2123-2133. (Pubitemid 36605823)
20. Tsilibary EC. Microvascular basement membranes in diabetes mellitus. J Pathol 2003; 200: 537-546. (Pubitemid 36818254)
21. Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51: 506-513. (Pubitemid 34764810)
22. Akimoto T, Ito C, Saito O, Takahashi H, Takeda S, Ando Y et al. Microscopic hematuria and diabetic glomerulosclerosis-clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria. Nephron Clin Pract 2008; 109: c119-c126.
23. Fü rnsinn C, Komjati M, Madsen OD, Schneider B, Waldhäusl W. Lifelong sequential changes in glucose tolerance and insulin secretion in genetically obese Zucker rats (fa/fa) fed a diabetogenic diet. Endocrinology 1991; 128: 1093-1099.
24. Sandler S, Welsh N. Interleukin-10 stimulates rat pancreatic islets in vitro, but fails to protect against interleukin-1. Biochem Biophys Res Commun 1993; 195: 859-865. (Pubitemid 23280495)
25. Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006; 26: 232-244. (Pubitemid 44114394)
26. Bjorn SF, Bangstad HJ, Hanssen KF, Nyberg G, Walker JD, Viberti GC et al. Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia 1995; 38: 1197-1204.
27. Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Goke B et al. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and the thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis. Am J Physiol Renal Physiol 2009; 296: F819-F829.
28. Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z. Irbesartan normalizes the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 2001; 44: 874-877. (Pubitemid 32642460)
29. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I et al. Nephrin in experimental glomerular disease. Kidney Int 2000; 58: 1461-1468.
30. Hollis JH, Lemus M, Evetts MJ, Oldfield BJ. Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression. Neuropharmacology 2010; 58: 730-738.
31. Okada T, Nomoto T, Yoshioka T, Nonaka-Sarukawa M, Ito T, Ogura T et al. Large-scale production of recombinant viruses by use of a large culture vessel with active gassing. Hum Gene Ther 2005; 16: 1212-1218. (Pubitemid 41443713)